Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application

被引:641
作者
Naseri, Neda [1 ,2 ]
Valizadeh, Hadi [3 ,4 ]
Zakeri-Milani, Parvin [4 ,5 ]
机构
[1] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Dept Med Nanotechnol, Fac Adv Med Sci, Tabriz, Iran
[3] Tabriz Univ Med Sci, Liver & Gastrointestinal Dis Res Ctr, Tabriz, Iran
[4] Tabriz Univ Med Sci, Fac Pharm, Tabriz, Iran
[5] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran
关键词
Colloidal carriers; SLNs; NLCs; physical stability; preparation methods;
D O I
10.15171/apb.2015.043
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipid nanoparticles (LNPs) have attracted special interest during last few decades. Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) are two major types of Lipid-based nanoparticles. SLNs were developed to overcome the limitations of other colloidal carriers, such as emulsions, liposomes and polymeric nanoparticles because they have advantages like good release profile and targeted drug delivery with excellent physical stability. In the next generation of the lipid nanoparticle, NLCs are modified SLNs which improve the stability and capacity loading. Three structural models of NLCs have been proposed. These LNPs have potential applications in drug delivery field, research, cosmetics, clinical medicine, etc. This article focuses on features, structure and innovation of LNPs and presents a wide discussion about preparation methods, advantages, disadvantages and applications of LNPs by focusing on SLNs and NLCs.
引用
收藏
页码:305 / 313
页数:9
相关论文
共 75 条
[1]  
AlHaj N.A., 2008, AM J PHARM TOXICOL, V3, P219, DOI [10.3844/ajptsp.2008.219.224, DOI 10.3844/AJPTSP.2008.219.224]
[2]   Nanotoxicology applied to solid lipid nanoparticles and nanostructured lipid carriers - A systematic review of in vitro data [J].
Doktorovova, Slavomira ;
Souto, Eliana B. ;
Silva, Amelia M. .
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2014, 87 (01) :1-18
[3]   Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications [J].
Araujo, J. ;
Gonzalez-Mira, E. ;
Egea, M. A. ;
Garcia, M. L. ;
Souto, E. B. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2010, 393 (1-2) :167-175
[4]  
Attama AA, 2012, PHARM TOXICOLOGY PHA
[5]  
Balazs DA, 2011, J DRUG DELIV, V2011, P326
[6]   Dextran-protamine coated nanostructured lipid carriers as mucuspenetrating nanoparticles for lipophilic drugs [J].
Beloqui, Ana ;
Angeles Solinis, Maria ;
des Rieux, Anne ;
Preat, Veronique ;
Rodriguez-Gascon, Alicia .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 468 (1-2) :105-111
[7]   Solid lipid nanoparticles for targeted brain drug delivery [J].
Blasi, Paolo ;
Glovagnoli, Stefano ;
Schoubben, Aurelie ;
Ricci, Maurizio ;
Rossi, Carlo .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :454-477
[8]   Production of solid lipid nanoparticle suspensions using supercritical fluid extraction of emulsions (SFEE) for pulmonary delivery using the AERx system [J].
Chattopadhyay, P. ;
Shekunov, B. Y. ;
Yim, D. ;
Cipolla, D. ;
Boyd, B. ;
Farr, S. .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (06) :444-453
[9]   Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans [J].
Cipolla, David ;
Shekunov, Boris ;
Blanchard, Jim ;
Hickey, Anthony .
ADVANCED DRUG DELIVERY REVIEWS, 2014, 75 :53-80
[10]   Recent Advances in Lipid Nanoparticle Formulations with Solid Matrix for Oral Drug Delivery [J].
Das, Surajit ;
Chaudhury, Anumita .
AAPS PHARMSCITECH, 2011, 12 (01) :62-76